International Journal of Cardiology
Volume 127, Issue 1 , Pages 70-77, 23 June 2008

Percutaneous intervention for posterior fossa ischemia. A single center experience and review of the literature

  • Edgardo Zavala-Alarcon

      Affiliations

    • University of Arizona School of Medicine, United States
    • Medicine Mayo Clinic School of Medicine, United States
    • Cardiology Department, Maricopa Medical Center, Phoenix Arizona, United States
    • Corresponding Author InformationCorresponding author. Cardiology Department, Maricopa Medical Center, 2601 E. Roosevelt St., Phoenix Az 85008, United States. Tel.: +1 602 344 5188; fax: +1 602 344 1233.
  • ,
  • Lisa Emmans

      Affiliations

    • Cardiology Department, Maricopa Medical Center, Phoenix Arizona, United States
  • ,
  • Renee Little

      Affiliations

    • Cardiology Department, Maricopa Medical Center, Phoenix Arizona, United States
  • ,
  • Ankur Bant

      Affiliations

    • Cardiology Department, Maricopa Medical Center, Phoenix Arizona, United States

Received 21 April 2006; received in revised form 3 May 2007; accepted 11 May 2007. published online 28 July 2007.

Abstract 

Objectives

The purpose of our study was to evaluate the results of endovascular treatment of symptomatic vertebro-basilar insufficiency (VBI) unresponsive to medical therapy.

Methods

Cardiac patients regularly followed in our cardiology clinic with symptoms suggestive of posterior fossa ischemia diagnosed by the attending cardiologist, had diagnostic or suspicious findings of vertebral artery stenosis on ultrasound evaluation, with reversed vertebral flow on Doppler examination. These patients were referred for selective vertebral and subclavian artery angiography. All patients (17 men, 11 women; mean age of 64 years, range 54–87) had critical lesions (> 70% stenosis) in the vertebral or pre-vertebral subclavian arteries or both. After confirmation of the severity of the lesions and feasibility for revascularization, all these patients underwent percutaneous intervention and stent placement. All patients were followed-up through clinic visits for a mean of 14.2 months, (range 3.5–24.3).

Results

In our 28 patients that were treated, 25 vertebral and 10 subclavian stents were placed. Success (< 20% residual diameter stenosis, without stroke or death) was achieved in 27 patients (96%). One patient undergoing intervention for an ostial subtotal occlusion of the left subclavian artery, developed a minor posterior fossa transient ischemic attack. At follow-up, 25 patients (89%) were alive and 22 (88%) of those had no further neurologic complaints. Three (11%) patients that had vertebral artery stents, died during follow-up from cardiac complications, unrelated to the neurovascular intervention. One patient (3.5%) had recurrent symptoms with in-stent restenosis at 6 months with successful balloon angioplasty and resolution of symptoms. The two other patients with persistent symptoms (only dizziness) had no evidence of restenosis and underwent further work-up that has not clarified the etiology.

Conclusions

Posterior fossa ischemia is an under-diagnosed condition that occurs with relative frequency in cardiac patients. Awareness of this condition and adequate non-invasive testing permits identification of these patients. Endovascular treatment using coronary wires and stents including drug eluting stents, seems to be the treatment of choice for vertebral artery revascularization due to the high technical success rate, low complication rate, and long-term durability.

Keywords: Vertebrobasilar syndrome, Vertebral artery stenosis, Posterior fossa ischemia, Percutaneous intervention, Stent, Subclavian

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-5273(07)01029-7

doi:10.1016/j.ijcard.2007.05.006

International Journal of Cardiology
Volume 127, Issue 1 , Pages 70-77, 23 June 2008